Here we noted two major effects induced by sEGFR treatment in EGFR wild type NSCLC cell lines: the first was the decrease in cell proliferation and cyclin D1 expression, the second was the blocking of the EGFR holoreceptor internalization. Here, CCND1 is linked to non-small cell lung carcinoma.